# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-054452
Filing Date
2024-05-07
Accepted
2024-05-07 16:03:34
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rphm-20240331.htm iXBRL | 10-Q | 1563920
2 | EX-31.1 | rphm-ex31_1.htm | EX-31.1 | 16379
3 | EX-31.2 | rphm-ex31_2.htm | EX-31.2 | 15913
4 | EX-32.1 | rphm-ex32_1.htm | EX-32.1 | 14614
5 | GRAPHIC | img28448619_0.jpg | GRAPHIC | 11204
| Complete submission text file | 0000950170-24-054452.txt |  | 5915770

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | rphm-20240331.xsd | EX-101.SCH | 992535
65 | EXTRACTED XBRL INSTANCE DOCUMENT | rphm-20240331_htm.xml | XML | 825808

Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 24921703
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)